Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership
Link up will utilise Brainomix’s AI software for the assessment of idiopathic pulmonary fibrosis
Read More
Author: John Pinching
PhoreMost in drug target discovery collaboration with Roche
PhoreMost will use Siteseeker platform to identify novel targets for Roche’s discovery programmes
Read More
BioInnovation Institute reveals new cohort entering Venture Lab programme
Group consists of nine ventures plus corporate-sponsored innovation projects from Novo Nordisk
Read More
New PM will ‘inherit an NHS in its most challenging state for decades’
Warning comes from NHS leaders as new Prime Minister prepares to move into Number 10
Read More
Sanofi and Regeneron’s Dupixent shows consistent safety profile
Study involving children aged six to 11 years with moderate-to-severe asthma reveals positive data
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
